Abeona Therapeutics

Shares of Abeona Therapeutics Inc (NASDAQ: ABEO) were trading higher by more than 11 percent Thursday after the company reported initial data from a 30-day study involving three Sanfillipo Type A patients treated with the company's therapy candidate ABO-102 at low doses (5E12vg/kg)....